At IntegerBio, we are committed to taking on some of the most serious diseases that threaten human health. Our mission is clear: harness the power of science, at the intersection of Virology, Oncology, and Immunology, to design broad, host-directed therapeutics with durable response across multiple diseases. We don’t do this alone. Our team is made up of a diverse group of brilliant industry experts, each bringing their unique perspectives and skills to advance a future without the fear of disease. Together, we drive cutting-edge biology and thoughtful, data-focused approaches to tune the immune system against multi-viral, oncologic, and inflammatory diseases. Our goal is simple yet ambitious: to combat disease, from the disruptive to catastrophic. We are doing the best work of our lives in service of yours.
| Website | https://integer.bio/ |
| Employees | 20 (20 on RocketReach) |
| Industry | Biotechnology Research |
| Keywords | Viral Therapeutics, Antiviral Drug Development, Immunology Research, Virology Research, Immunotherapies, Viral Vectors, Infectious Disease Research, Therapeutic Development, Pharmaceutical Research, Vaccine Development, Drug Discovery, Infectious Disease, Biotechnology, Disease Research, Biomedical Research, Human Health, Scientific Research |
| Competitors | Twist Bioscience, Geno, Zymergen, Inc., Moderna Therapeutics, Benson Hill, Amyris, Lygos, Arzeda, Ecovative, Ceres, Inc. +38 more (view full list) |
Looking for a particular IntegerBio employee's phone or email?
Atul Saran is the CEO of IntegerBio.
20 people are employed at IntegerBio.
IntegerBio is based in Gaithersburg, Maryland.